297 related articles for article (PubMed ID: 31265168)
1. Role of lactadherin in intestinal barrier integrity in experimental neonatal necrotizing enterocolitis.
Shen H; Lei Y; He X; Liu D; He Z
J Cell Biochem; 2019 Dec; 120(12):19509-19517. PubMed ID: 31265168
[TBL] [Abstract][Full Text] [Related]
2. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model.
Rentea RM; Liedel JL; Welak SR; Cassidy LD; Mayer AN; Pritchard KA; Oldham KT; Gourlay DM
J Pediatr Surg; 2012 Jun; 47(6):1135-42. PubMed ID: 22703783
[TBL] [Abstract][Full Text] [Related]
3. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
Khailova L; Dvorak K; Arganbright KM; Halpern MD; Kinouchi T; Yajima M; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G940-9. PubMed ID: 20501441
[TBL] [Abstract][Full Text] [Related]
4. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
Clark JA; Doelle SM; Halpern MD; Saunders TA; Holubec H; Dvorak K; Boitano SA; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.
Ling X; Linglong P; Weixia D; Hong W
PLoS One; 2016; 11(8):e0161635. PubMed ID: 27551722
[TBL] [Abstract][Full Text] [Related]
6. Intestinal epithelial tight junctions and permeability can be rescued through the regulation of endoplasmic reticulum stress by amniotic fluid stem cells during necrotizing enterocolitis.
Li B; Lee C; Chuslip S; Lee D; Biouss G; Wu R; Koike Y; Miyake H; Ip W; Gonska T; Pierro A
FASEB J; 2021 Jan; 35(1):e21265. PubMed ID: 33373067
[TBL] [Abstract][Full Text] [Related]
7. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis.
Bergmann KR; Liu SX; Tian R; Kushnir A; Turner JR; Li HL; Chou PM; Weber CR; De Plaen IG
Am J Pathol; 2013 May; 182(5):1595-606. PubMed ID: 23470164
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan 35 kDa enhances epithelial barrier function and protects against the development of murine necrotizing enterocolitis.
Gunasekaran A; Eckert J; Burge K; Zheng W; Yu Z; Kessler S; de la Motte C; Chaaban H
Pediatr Res; 2020 Jun; 87(7):1177-1184. PubMed ID: 31499514
[TBL] [Abstract][Full Text] [Related]
9. Necrotizing enterocolitis leads to disruption of tight junctions and increase in gut permeability in a mouse model.
Ravisankar S; Tatum R; Garg PM; Herco M; Shekhawat PS; Chen YH
BMC Pediatr; 2018 Nov; 18(1):372. PubMed ID: 30482190
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis.
Seo S; Miyake H; Alganabi M; Janssen Lok M; O'Connell JS; Lee C; Li B; Pierro A
J Pediatr Surg; 2019 Dec; 54(12):2520-2523. PubMed ID: 31668399
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model.
Tian F; Liu GR; Li N; Yuan G
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4711-4719. PubMed ID: 29131241
[TBL] [Abstract][Full Text] [Related]
12. Rho kinase inhibition maintains intestinal and vascular barrier function by upregulation of occludin in experimental necrotizing enterocolitis.
Grothaus JS; Ares G; Yuan C; Wood DR; Hunter CJ
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G514-G528. PubMed ID: 29927318
[TBL] [Abstract][Full Text] [Related]
13. DRG1 Maintains Intestinal Epithelial Cell Junctions and Barrier Function by Regulating RAC1 Activity in Necrotizing Enterocolitis.
Lu L; Xu W; Liu J; Chen L; Hu S; Sheng Q; Zhang M; Lv Z
Dig Dis Sci; 2021 Dec; 66(12):4237-4250. PubMed ID: 33471252
[TBL] [Abstract][Full Text] [Related]
14. Human β-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model.
Sheng Q; Lv Z; Cai W; Song H; Qian L; Mu H; Shi J; Wang X
Pediatr Res; 2014 Sep; 76(3):269-79. PubMed ID: 24956228
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A and Retinoic Acid Exhibit Protective Effects on Necrotizing Enterocolitis by Regulating Intestinal Flora and Enhancing the Intestinal Epithelial Barrier.
Xiao S; Li Q; Hu K; He Y; Ai Q; Hu L; Yu J
Arch Med Res; 2018 Jan; 49(1):1-9. PubMed ID: 29699808
[TBL] [Abstract][Full Text] [Related]
16. Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment.
Khailova L; Dvorak K; Arganbright KM; Williams CS; Halpern MD; Dvorak B
Pediatr Res; 2009 Aug; 66(2):140-4. PubMed ID: 19390485
[TBL] [Abstract][Full Text] [Related]
17. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model.
Caplan MS; Miller-Catchpole R; Kaup S; Russell T; Lickerman M; Amer M; Xiao Y; Thomson R
Gastroenterology; 1999 Sep; 117(3):577-83. PubMed ID: 10464133
[TBL] [Abstract][Full Text] [Related]
18. Human placental-derived stem cell therapy ameliorates experimental necrotizing enterocolitis.
Weis VG; Deal AC; Mekkey G; Clouse C; Gaffley M; Whitaker E; Peeler CB; Weis JA; Schwartz MZ; Atala A
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G658-G674. PubMed ID: 33566727
[TBL] [Abstract][Full Text] [Related]
19. Causative role of mast cell and mast cell-regulatory function of disialyllacto-N-tetraose in necrotizing enterocolitis.
Zhang W; He-Yang J; Zhuang W; Liu J; Zhou X
Int Immunopharmacol; 2021 Jul; 96():107597. PubMed ID: 33812262
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
Clark JA; Lane RH; Maclennan NK; Holubec H; Dvorakova K; Halpern MD; Williams CS; Payne CM; Dvorak B
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
